Medical Policies
Home
Category Filter
policies & guidelines
Blue Advantage Policies
Provider-Administered Drug Policies
Current Provider-Administered Drug Policies
Draft Provider-Administered Drug Policies
HelpScript Program
Hemophilia Drugs
Draft Hemophilia Drug Policies
Final Hemophilia Drug Policies
Hemophilia Drug Prior Authorization
PEEHIP Hemophilia Drug Program
Provider-Administered Drug Policies
Draft Provider-Administered Drug Policies
Drug Wastage Program
Final Provider-Administered Drug Precertification Policies
Mandatory Site of Service
Provider-Administered Drug Claim Edit Policies
Voluntary Site of Service
Self-Administered Drug Policies
Final Self-Administered Drug Policies
Self-Administered Drug Prior Authorization Forms
Asset Publisher
< Back to Final Blue Advantage
®
Medical Policies page
Final Policies: K - N
Policy #
Policy Title
View
BA-322
Laboratory Testing for HIV Tropism
BA-208
Laparoscopic and Percutaneous Techniques for the Myolysis of Uterine Fibroids
BA-103
Lipid Apheresis
BA-070
Locoregional Therapies for Hepatocellular Carcinoma and Metastatic Liver Carcinoma and Metastatic Carcinoid Tumors of the Liver
BA-270
Low-Level Laser Therapy
BA-178
Magnetic Resonance Guided Focused Ultrasound (MRgFUS)
BA-338
Magnetoencephalography-Magnetic Source Imaging
BA-158
Meniscal Allografts and Other Meniscus Implants
BA-512
Microwave Tumor Ablation
BA-124
Myoelectric Prosthetic and Orthotic Components for the Upper Limb
BA-392
Nerve Fiber Density Measurement
BA-237
Noninvasive Techniques for the Evaluation and Monitoring of Patients with Chronic Liver Disease
BA-166
Nonpharmacologic Treatment of Rosacea
Hidden